Community Outreach

To successfully conduct and deliver patient-centered treatment and research, it is necessary to have broad outreach into the community. This form of collaboration not only takes important new findings to the community, but also elicits input from the community. Karmanos physicians are actively involved in patient education through a variety of outlets. These include:

  • Speaking engagements at local organizations for individuals diagnosed with cancer to educate patients and family members on advances in a variety of cancers with specific emphasis on the emergence of therapies based on molecular characteristics of the cancer
  • Participation in media-organized forums such as web based ‘chats’ that educate the community on cancer screening and prevention  
  • Developed the Karmanos Prostate Cancer Advocacy Program (PCAP), a comprehensive team of providers dedicated to the prevention and cure of prostate cancer by embracing the patient and family perspective
  • Within PCAP, a prostate cancer education program was developed to specifically reach African-Americans in the Detroit community
  • Involvement in community-based support programs for pediatric cancer patients. 

Physician Outreach

An additional important component of community outreach involves physician education. Karmanos, and our physicians, regularly participates in a variety of educational opportunities.

  • Annual conferences regarding updates for breast cancer, gastrointestinal cancer, thoracic oncology and others are offered through Karmanos
  • Participation in the yearly Board Review Symposium organized by the Michigan Society of Hematology and Oncology  
  • Collaboration with community physicians by providing information on available clinical trials at Karmanos, thus providing patients access to novel investigational agents when other treatment options have failed

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Detroit Cancer Center Unveils New Device for Treating Liver Cancer at Home

The Detroit News The TheraBionic P1 device is now available for patients who have advanced liver cancer and have failed first- and second-line the...

Read More

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

The Barbara Ann Karmanos Cancer Institute , the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announce...

Read More

CURE, in Collaboration with Karmanos' Office of Cancer Health Equity and Community Engagement, Educates the Community About Metastatic Breast Cancer

On Wednesday, Dec. 4, 2024, patients, survivors, and advocates gathered at Karmanos Cancer Institute in Detroit to learn about metastatic breast c...

Read More
News

WDET | Scholarship Program Aims to Encourage More Diversity in Clinical Trials

Listen Now

101 WRIF | Lung Cancer Awareness

Listen Now

Becker’s Healthcare Podcast | Exploring Breakthroughs in Cancer Treatment with Dr. Boris C. Pasche, President & CEO at Karmanos Cancer Institute

Listen Now